Seminars in Hematology
| 短名 | Semin. Hematol. |
| Journal Impact | 4.84 |
| 国际分区 | HEMATOLOGY(Q1) |
| 期刊索引 | SCI Q2中科院 3 区 |
| ISSN | 0037-1963, 1532-8686 |
| h-index | 103 |
| 国内分区 | 医学(3区)医学血液学(3区) |
血液学研讨会旨在介绍临床血液学中当前重要的主题，包括肿瘤学、血液病理学和血库的相关领域。该杂志独特的期刊结构允许通过精选的评论文章对单个主题进行多方面的概述，同时还提供各种文章，展示立即影响该领域的动态和前沿材料。血液学研讨会是致力于使对血液疾病有浓厚兴趣的执业医师、年轻研究者、临床从业者和内科医生/儿科医生能够访问、理解和有价值的重要和当前工作。血液学研讨会发表原创研究、评论、简短的交流和小型评论。
期刊主页投稿网址| 涉及主题 | 医学生物内科学免疫学遗传学病理化学生物化学心理学外科精神科 |
| 出版信息 | 出版商: W.B. Saunders，出版周期: Quarterly，期刊类型: journal |
| 基本数据 | 创刊年份: 1964，原创研究文献占比: 95.45%，自引率:2.00%， Gold OA占比: 20.69% |
| 平均审稿周期 | 网友分享经验：>12周，或约稿 |
| 平均录用比例 | 网友分享经验：一般 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Accelerating Accessibility of CAR-T/NK therapies – Are AlloCARs and rapid manufacturing platforms the road ahead in improving access in multiple myeloma?
2024-9-1
Infections and antimicrobial prophylaxis in patients with myelodysplastic syndromes
2024-8-1
Mobilizing CARs: Benefits, Drawbacks, and Directions for Outpatient CAR T-cell therapy
2024-8-1
Beyond HMAs: Novel targets and therapeutic approaches
2024-8-1
The road more or less traveled- Examining the role of consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T cell therapy in B-cell ALL
2024-8-1
CARs moving forward: The development of CAR T-cell therapy in the earlier treatment course of hematologic malignancies
2024-8-1
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19
2024-8-1
License for a CAR T: Examining Patient Eligibility
2024-7-1
Tuning CAR T-cell therapies for efficacy and reduced toxicity
2024-7-1
Fast and furious: Changing gears on the road to cure with chimeric antigen receptor T cells in multiple myeloma
2024-7-1
The Management of Older Patients with Hodgkin Lymphoma: Implications of S1826
2024-6-1
Updates on the biology of chronic lymphocytic leukemia: introductory editorial
2024-6-1
Role of the tumor microenvironment in CLL pathogenesis
2024-6-1
The Role of Response Adapted Therapy in the Era of Novel Agents
2024-6-1
The Role of Autologous Stem-cell Transplantation in Classical Hodgkin Lymphoma in the Modern Era
2024-6-1
Biological, prognostic, and therapeutic impact of the epigenome in CLL
2024-6-1
Metabolic reprogramming in the CLL TME; potential for new therapeutic targets
2024-6-1
outside front cover, PMS 8883 metallic AND 4/C
2024-6-1
Lessons learned from the Eµ-TCL1 mouse model of CLL
2024-6-1
Molecular biomarkers in classic Hodgkin lymphoma
2024-5-1
The Biology of Classical Hodgkin Lymphoma
2024-5-1
Contemporary Radiation Therapy use in Hodgkin Lymphoma
2024-5-1
The Pediatric Approach to Hodgkin Lymphoma
2024-5-1
The complexities of T cell dysfunction in Chronic Lymphocytic Leukemia
2024-4-1
outside front cover, PMS 8883 metallic AND 4/C
2024-4-1
Mouse models of CLL: in vivo modeling of disease initiation, progression, and transformation to Richter transformation
2024-4-1
The molecular map of CLL and Richter's syndrome
2024-4-1
Targeting the B Cell Receptor Signaling Pathway in Chronic Lymphocytic Leukemia
2024-4-1
B cell receptor immunoglobulin stereotypy in chronic lymphocytic leukemia: Key to understanding disease biology and stratifying patients
2024-4-1
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial
2024-3-26
miRNA Biology in Chronic Lymphocytic Leukemia
2024-3-19
Prognostication in chronic lymphocytic leukemia
2024-3-1
Clonal hematopoiesis and autoimmunity
2024-2-1
Clonal hematopoiesis
2024-2-1
A tower of babel of acronyms? The shadowlands of MGUS/MBL/CHIP/TCUS
2024-2-1
Clonal hematopoiesis in the setting of hematopoietic cell transplantation
2024-2-1
Therapeutic targeting of apoptosis in chronic lymphocytic leukemia
2024-2-1
outside front cover, PMS 8883 metallic AND 4/C
2024-2-1
Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence
2024-2-1
Germline predisposition for clonal hematopoiesis
2024-2-1
The crossroads of cancer therapies and clonal hematopoiesis
2024-2-1
TET2 mutation as prototypic clonal hematopoiesis lesion
2024-2-1
Vaccinations in patients with chronic lymphocytic leukemia
2024-1-1
CLONAL HEMATOPOIESIS IN CHILDREN WITH PREDISPOSING CONDITIONS
2024-1-1
Transforming CLL management with immunotherapy: Investigating the potential of CAR T-cells and bispecific antibodies
2024-1-1
Role of the tumor microenvironment in CLL pathogenesis
2023-12-26
B cell receptor immunoglobulin stereotypy in chronic lymphocytic leukemia: Key to understanding disease biology and stratifying patients
2023-12-26
Second-line treatment of diffuse large B‐cell lymphoma: Evolution of options
2023-12-1
CD19 CAR-T cell therapy for Relapsed or Refractory Diffuse Large B Cell Lymphoma; Why does it Fail?
2023-12-1
Epidemiology and Etiology of Diffuse Large B-Cell Lymphoma (DLBCL)
2023-11-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远